(Q34197501)

English

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

Mariana Chavez-MacGregor

object named as

Mariana Chavez-Macgregor

1

0 references

Sharon H. Giordano

object named as

Sharon H Giordano

4

0 references

Antonio C. Wolff

object named as

Antonio C Wolff

6

0 references

Ana Maria Gonzalez-Angulo

10

object named as

Ana Maria Gonzalez-Angulo

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Gabriel N Hortobagyi

8

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Jennifer Litton

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Huiqin Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Clifford A Hudis

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Vicente Valero

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Melissa L Bondy

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4168-4177

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Rethinking the Hispanic paradox: death rates and life expectancy for US non-Hispanic White and Hispanic populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Aging, migration, and mortality: current status of research on the Hispanic paradox

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Paradox lost: explaining the Hispanic adult mortality advantage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Interpreting the paradoxical in the hispanic paradox: demographic and epidemiologic approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Tumor characteristics in African American and white women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Understanding the Hispanic paradox

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

Pathological assessment of response to induction chemotherapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

5 July 2018

The relation between health insurance coverage and clinical outcomes among women with breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Race, socioeconomic status, and breast cancer treatment and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Differences in breast cancer stage, treatment, and survival by race and ethnicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

Breast cancer among Hispanic and non-Hispanic White women in Arizona.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25296

21 January 2018

CYP2D6 genetic variation in healthy adults and psychiatric African-American subjects: implications for clinical practice and genetic testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954673

28 October 2018

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Black/white differences in type of initial breast cancer treatment and implications for survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear structure in cancer tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ethnicity and breast cancer: factors influencing differences in incidence and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hispanic paradox in biological risk profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564153

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.25296

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34197501&oldid=1958458270"